A novel Tandem-CAR encoding an anti-FRα scFv, an anti-MSLN scFv, and two peptide sequences of IL-12 were designed to improve the efficacy, infiltration, persistence, and proliferation of CAR-T cell in ovarian cancer (107). This evidence concerns the gene FOLR1 and ovarian carcinoma.